TC
Tsai Capital Portfolio holdings
AUM
$136M
This Quarter Return
+7.96%
1 Year Return
+16.91%
3 Year Return
+81.58%
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(+7.6%)
Cap. Flow
+$8.13M
Cap. Flow
% of AUM
7.47%
Top 10 Holdings %
Top 10 Hldgs %
85.73%
Holding
18
New
–
Increased
7
Reduced
8
Closed
–
Top Buys
| 1 |
CoStar Group
CSGP
|
$5.82M |
| 2 |
Trade Desk
TTD
|
$3.85M |
| 3 |
Spotify
SPOT
|
$1.31M |
| 4 |
Snowflake
SNOW
|
$1.17M |
| 5 |
Tesla
TSLA
|
$256K |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.52M |
| 2 |
Apple
AAPL
|
$1.35M |
| 3 |
Amazon
AMZN
|
$509K |
| 4 |
Zillow
Z
|
$353K |
| 5 |
Nike
NKE
|
$299K |
Sector Composition
| 1 | Consumer Discretionary | 35.79% |
| 2 | Technology | 28.57% |
| 3 | Communication Services | 21.95% |
| 4 | Real Estate | 5.91% |
| 5 | Consumer Staples | 4.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tesla
TSLA
$1.06T
| $26.3M | 24.14% |
38,685
+377
| +1% | +$256K |
|
|
2
Apple
AAPL
$3.4T
| $21.3M | 19.6% |
155,878
-9,866
| -6% | -$1.35M |
|
|
3
Amazon
AMZN
$2.4T
| $7.2M | 6.62% |
2,094
-148
| -7% | -$509K |
|
|
4
Alphabet (Google) Class C
GOOG
$2.55T
| $6.78M | 6.22% |
2,703
-607
| -18% | -$1.52M |
|
|
5
CoStar Group
CSGP
$37.2B
| $6.44M | 5.91% |
77,760
+70,241
| +934% | +$5.82M |
|
|
6
Snowflake
SNOW
$77.8B
| $6.39M | 5.87% |
26,425
+4,848
| +22% | +$1.17M |
|
|
7
Spotify
SPOT
$142B
| $5.74M | 5.27% |
20,821
+4,749
| +30% | +$1.31M |
|
|
8
Nike
NKE
$110B
| $4.66M | 4.28% |
30,147
-1,937
| -6% | -$299K |
|
9
Costco
COST
$416B
| $4.37M | 4.01% |
11,037
+6
| +0.1% | +$2.37K |
|
|
10
Trade Desk
TTD
$26.3B
| $4.15M | 3.81% |
53,630
+49,732
| +1,276% | +$3.85M |
|
11
Netflix
NFLX
$516B
| $4.03M | 3.7% |
7,628
+306
| +4% | +$162K |
|
12
Salesforce
CRM
$240B
| $3.37M | 3.09% |
13,795
-1,054
| -7% | -$257K |
|
|
13
Zillow
Z
$19.8B
| $3.21M | 2.95% |
26,251
-2,885
| -10% | -$353K |
|
14
Visa
V
$677B
| $2.83M | 2.6% |
12,093
-50
| -0.4% | -$11.7K |
|
15
McDonald's
MCD
$225B
| $820K | 0.75% |
3,550
| – | – |
|
16
AbbVie
ABBV
$374B
| $496K | 0.46% |
4,400
| – | – |
|
17
Johnson & Johnson
JNJ
$429B
| $405K | 0.37% |
2,460
-800
| -25% | -$132K |
|
18
Merck
MRK
$212B
| $383K | 0.35% |
4,921
| – | – |
|